HALEY MILLER: Open Payments
NPI 1396388997 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$344 in 20 payments from 10 companies in 2025. Trend: 2023 $457 · 2024 $209 · 2025 $344
Food & beverage: $344
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 9 | $131 |
| Exeltis, USA Inc. | 2 | $48 |
| SHIELD THERAPEUTICS INC | 2 | $38 |
| MILLICENT US INC | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Siemens Medical Solutions USA, Inc. | 1 | $16 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
| Sage Therapeutics, LLC | 1 | $16 |
Products named: SLYND, ACCRUFER, FEMLYV, Mirena, Veozah, MYFEMBREE, MicroThermX Microwave Ablation System, Qelbree.
Industry payments across AL — which companies pay providers there.
